Jump to content

User:Wowbagger2/sandbox

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Wowbagger2 (talk | contribs) at 13:21, 15 December 2017. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Wowbagger2/sandbox
Clinical data
Trade namesAliqopa (US)
Other namesBAY 80-6946
AHFS/Drugs.comAliqopa
MedlinePlusa617044
License data
Routes of
administration
intravenous infusion only
Drug classPI3-Kinase inhibitor
ATC code
  • none
Legal status
Legal status
Pharmacokinetic data
Protein binding84.2%[1]
MetabolismCYP3A4/5 (~90%), CYP1A1 (~10%)[1]
Elimination half-life39.1 hours (range: 14.6 to 82.4)[1]
ExcretionFeces (64%), Urine (22%); 14% were not recovered
Identifiers
  • 2-Amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC23H28N8O4
Molar mass480.529 g·mol−1
3D model (JSmol)
  • COC1=C(C=CC2=C1N=C(N3C2=NCC3)NC(=O)C4=CN=C(N=C4)N)OCCCN5CCOCC5
  1. ^ a b c Cite error: The named reference AliPI was invoked but never defined (see the help page).